NP
Natraj Pola
About Natraj Pola
Data last updated:
Natraj Pola has 15 years in corporate governance. Holds Director role. Currently with 3 companies, including Hansa Kakatiya Constructions Private Limited and Halden Healthcare & Research Private Limited. Formerly with 1 company, such as Bhavithasri Chit Funds Private Limited. Engaged in General Business, Healthcare. Contributes to corporate operations.
Current companies
| Company | Designation | Appointment | Founded | Status |
|---|---|---|---|---|
 Hansa Kakatiya Constructions Private Limited U70100TG2015PTC098586 | Director | 03 Feb 2016 | 2015 | Active |
 Halden Healthcare & Research Private Limited U74900TG2015PTC101641 | Director | 09 Nov 2015 | 2015 | Active |
| Samraksha Health Care Private Limited U85110TG2013PTC089773 | Director | 15 Jun 2016 | 2013 | Active |
Previous companies
| Company | Designation | Appointment | Founded | Status |
|---|---|---|---|---|
 Bhavithasri Chit Funds Private Limited U65910TG2011PTC074793 | Director | 02 Jun 2011 | 2011 | Active |
Explore Director's current and past company associations Uncover their professional journey today!
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Natraj Pola
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Natraj Pola
Natraj Pola has 15 years in corporate governance. Holds Director role. Currently with 3 companies, including Hansa Kakatiya Constructions Private Limited and Halden Healthcare & Research Private Limited. Formerly with 1 company, such as Bhavithasri Chit Funds Private Limited. Engaged in General Business, Healthcare. Contributes to corporate operations.
Natraj Pola is associated with 3 companies as Director.
Natraj Pola has expertise in General Business, Healthcare.
Natraj Pola has 15 years in corporate governance.